dgac384.pdf (220.99 kB)
Download file

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions

Download (220.99 kB)
journal contribution
posted on 05.08.2022, 09:23 authored by Francesco Zaccardi, Kamlesh Khunti

Over the course of the COVID-19 pandemic, epidemiological investigations have explored the risk of various medical conditions following the acute phase of the COVID-19 infection. Although variable definitions and terms have been proposed, this cluster of conditions—encompassing mental health, neurological, metabolic, cardiorespiratory, gastrointestinal, musculoskeletal, coagulative, renal, and dermatological disorders—is commonly referred to as “post-acute sequelae of SARS-CoV-2 infection” or “long-COVID” syndrome (1). 

Funding

National Institute for Health Research (NIHR) – Applied Research Collaboration (ARC) East Midlands

History

Author affiliation

Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester

Version

VoR (Version of Record)

Published in

The Journal of Clinical Endocrinology & Metabolism

Publisher

Oxford University Press for Endocrine Society

issn

0021-972X

eissn

1945-7197

Acceptance date

21/06/2022

Copyright date

2022

Available date

05/08/2022

Spatial coverage

United States

Language

English